THE phorbol diester, 12-0-tetradecanoylphorbol-1 3-acetate (TPA) and various other tumour promoters affect cells in culture at various levels and in a variety of ways (Slaga et al., 1978) . It is now increasingly appreciated that tumour promoters can affect mononuclear phagocytes at different levels and with opposite consequences: (1) precursors of the mononuclear phagocyte lineage are selectively stimulated to proliferate and differentiate into macrophages, thus mimicking the effects of macrophage colony-stimulating activity (Stuart & Hamilton, 1980; Keller & Keist, submitted for publication); (2) spontaneous cytolytic activity expressed by macrophages and by "natural killer" (NK) cells is suppressed (Keller, 1979) ; (3) the capacity of induced, activated macrophages to manifest immunologically non-specific cytotoxicity against a large array of tumour targets is clearly reduced (Keller, 1979) ; and (4) interaction of activated macrophages with TPA triggers the killing of target cells susceptible to H202 (Nathan et al., 1979) . In showing that lymphokine-induced macrophage activation is effectively suppressed by TPA and various other tumour promoters, the present work provides further evidence for the manifold and often ambiguous effects of these agents.
Peritoneal wash-outs from normal DA rats or C3H/J mice were seeded into 35 mm plastic Petri dishes and incubated for 2 h at 37°C. After intensive washing, Accepted 30 September 1981 the cells remaining adherent were used as a source of effector cells (Keller, 1978) . To enhance their non-specific cytolysis the resting adherent peritoneal cells were interacted for 8 h with macrophageactivating lymphokines (MAL; a cell-free supernatant from 72h cultures of rat spleen cells in serum-free RPMI-1640 medium supplemented with 5 Hg/ml concanavalin A (Sigma); final concentration 20%) and then washed. DA rat polyomainduced tumour cells (Keller, 1978) were used as target cells, having been prelabelled with [14C]-dT (methyl-14C-dT 40-60 mCi/mmol; New England Nuclear, Boston, Mass.) as previously described (Keller & Keist, 1978) and then interacted with effector cells for 36 h at 37°C (initial effector/target cell ratio 10: 1). The released radioactivity was then measured and net cytotoxicity calculated (Keller, 1978) .
The results with rat effector cells, presented in the Table, show that the phorbol esters TPA (Hecker, 1978) and phorbol-12,1 3-didecanoate (PDD; Hecker, 1978) as well as the loa-alkyldaphnane, Pimelea factor P2 (Zayed et al., 1977) in a final concentration of 10-8M, are comparably active in suppressing spontaneous and in preventing lymphokine-induced enhancement of macrophage tumoricidal activity. It is noteworthy that manifestation of spontaneous macrophage cytotoxicity was similarly inhibited whether effector cells were first pretreated for 4 h TPA PREVENTS MACROPHAGE ACTIVATION (Keller, 1973) and cytotoxicity assessed with the [14C]-dTrelease assay (Keller & Keist, 1978) . Results represent the mean + s.d. %O net isotope release from 6 cultures each. *These values are significantly different (P < 0 -001; t test) from controls.
with tumour promoters and the washed effector cells then interacted with prelabelled targets (not shown) or whether the promoting agents were present throughout the 36 h effector/target-cell interaction (Table) . Enhancement by lymphokines of macrophage-mediated long-term cytotoxicity was similarly abrogated when tumour promoters were present only during the 8h activation (Table) or only during the effector/target-cell interaction. Similar results were obtained with effector cells derived from C3H/J mice.
In addition to the earlier evidence that manifestation of cytotoxicity by NK cells and by resting and previously activated macrophages is markedly suppressed by tumour promoters (Keller, 1979 ) the present work attests to the ability of active promoters of the phorbol diesterand daphnane-type to prevent lymphokine-induced enhancement of macrophage cytolysis. In showing that agents with different structure but comparably potent tumour-promoting activity in mouse skin (such as the phorbol esters TPA and PDD and the lo-alkyldaphnane Pimelea factor P2) are similarly active in suppressing the activation for and the manifestation of cytotoxicity by rat and mouse macrophages, the present findings suggest that this capacity may be common to all tumour promoters. Such a conclusion is further supported by the present and earlier (Keller, 1979) demonstration that 10* agents structurally closely related to the active phorbol esters but without tumourpromoting activity, such as phorbol (Hecker & Schmidt, 1974) and 4a-phorbol-12,13-didecanoate (4cx-PDD; Hecker, 1978) , were inactive in this experimental model.
The mechanism by which acquisition and manifestation of cytotoxicity by macrophages is affected, is still far from being understood. This is not surprising in view of the various possible mechanisms for the mediation of immunologically non-specific macrophage cytotoxicity (Keller, 1981) and the diversity of effects exerted by tumour promoters on cells in culture (Slaga et al., 1978; Keller, 1979; Nathan et al., 1979; Stuart & Hamilton, 1980; Keller & Keist submitted) . However, there is varied rather conclusive evidence that in the concentration used, tumour promoters do not impair the function of effector and target cells. This conclusion is supported by numerous observations attesting to the capacity of tumour promoters to induce or enhance in various cell types a variety of functions. In mononuclear phagocytes, these agents are able, among many other things, to induce proliferation and differentiation in marrow precursors and to trigger in activated macrophages H202-mediated short-term cytotoxicity. Together with earlier work, the present findings lend further support to the concept that tumour promoters facilitate the outgrowth of transformed cells by two major mechanisms: (1) the stimulation of their multiplication and functional capacities and (2) the suppression of the host's cellular antitumour effector systems.
